Lynestrenol

CHEMBL2107431 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
284.4 g/mol
LogP
4.5
Phase
4

A synthetic progestin used in oral contraceptives and to treat gynecological conditions such as endometriosis, dysfunctional uterine bleeding, and premenstrual syndrome. It is converted to norethisterone in the body to exert its progestogenic effects.

Masse moléculaire

284,4000 g/mol

LogP

4,50

TPSA

20,20 Ų

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C

InChI

InChI=1S/C20H28O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h1,6,15-18,21H,4-5,7-13H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1

Molecular Formula

C20H28O

HBD / HBA

1 / 1

Liaisons Rotatives

1

Atomes Lourds

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A synthetic progestin used in oral contraceptives and to treat gynecological conditions such as endometriosis, dysfunctional uterine bleeding, and premenstrual syndrome. It is converted to norethisterone in the body to exert its progestogenic effects.

Yes, Lynestrenol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2107431. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5857. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.